Significance of Presepsin in the Early Diagnosis of Sepsis in Children

Hamraeva G. SH.; Razikova Sh. K.; Mirakbarova N. T.

Authors

Hamraeva G. SH. Center for the development of professional skills of medical workers
Razikova Sh. K. Republican Scientific Center of Emergency Medical Care
Mirakbarova N. T. Republican Scientific Center of Emergency Medical Care

Vol. 2 No. 8 (2024): International Journal of Integrative and Modern Medicine

Articles

August 24, 2024

Resume.

Infectious processes occurring in children of early age often have a non-specific clinical appearance. This, in turn, can lead to interpretation of symptoms and late diagnosis of the disease.

The purpose of the study is to determine the significance of the amount of presepsin in the blood plasma in the early diagnosis of sepsis in young children.

Materials and methods. 62 children with early age sepsis were included in the study. Among them, 27 patients made up the comparison group, i.e. children not complicated by sepsis, and 35 patients made up the main group - children with sepsis caused by pneumonia.

Result. When the level of presepsin was checked on the 1st-3rd days of hospitalization, it was found that the level of presepsin in the blood plasma of the patients of the main group was significantly higher than that of the patients of the control group. (358.9 [279.8 – 675.7] and 245.6 [125-353]). In addition, it was found that there is a correlation (r<0.05) between the duration of time the patients on the mechanical ventilator and the high level of presepsin in the blood (R=0.34; r=0.02).

Conclusion. Presepsin level in blood plasma exceeding 325 ng/l can serve as a diagnostic critery for the possibility of sepsis in the background of pneumonia.

G. SH., H., Sh. K., R., & N. T., M. (2024). Significance of Presepsin in the Early Diagnosis of Sepsis in Children. International Journal of Integrative and Modern Medicine, 2(8), 72–76. Retrieved from https://medicaljournals.eu/index.php/IJIMM/article/view/876

Download Citation

Hooven, T. A. Pneumonia / T. A. Hooven, R. A. Polin // Semin. Fetal Neonatal Med. – 2017 Aug. – Vol. 22, N 4. – Р. 206–213.

Transient tachypnoea of the newborn and congenital pneumonia: a comparative study / S. Costa [et al.] // J. Matern. Fetal Neonatal Med. – 2012 Jul. – Vol. 25, N 7. – Р. 992–994.

Pediatric severe sepsis: current trends and outcomes from the pediatric health information systems database / A. Ruth [et al.] // Pediatr. Crit. Care Med. – 2014 Nov. – Vol. 15, N 9. – Р. 828–838.

Diagnostic accuracy of presepsin (sCD14-ST) to predict bacterial infection measured in cerebrospinal fluid in children with suspected bacterial meningitis ventriculitis / D. Stubljar [et al.] // J. Clin. Microbiol. – 2015 Apr. – Vol. 53, N 4.Р. 1239–1244.

CD14 is an acute-phase protein / S. Bas [et al.] // J. Immunol. – 2004 Apr. – Vol. 172, N 7. – Р. 4470–4479.

Presepsin (sCD14-ST), an innate immune response marker in sepsis / C. Chenevier-Gobeaux [et al.] // Clin. Chim. Acta. – 2015 Oct. – Vol. 450. – Р. 97–103.

Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study / S. Endo [et al.] // J. Infect. Chemother. – 2012 Dec. – Vol. 18, N 6. – Р. 891–897.

Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study / M. Ulla [et al.] // Crit. Care. – 2013 Jul. – Vol. 17, N 4. – R168.

Presepsin (soluble CD14 subtype): reference ranges of a new sepsis marker in term and preterm neonates / L. Pugni [et al.] // PLoS One. – 2015 Dec. – Vol. 10, N 12. – e0146020.

Comparison between presepsin and procalcitonin in early diagnosis of neonatal sepsis / A. Iskandar [et al.] // J. Matern. Fetal. Neonatal. Med. – 2018 Dec. – Vol. 32, N 23. – P. 3903–3908.

Presepsin for the detection of late-onset sepsis in preterm newborns / C. Poggi [et al.] // Pediatrics. – 2015 Jan. – Vol. 135, N 1. – Р. 68–75.

Presepsin for the detection of early-onset sepsis in preterm newborns / P. Montaldo [et al.] // Pediatr. Res. – 2017 Feb. – Vol. 81, N 2. – Р. 329–334.

Levy, O. Innate immunity of the newborn: basic mechanisms and clinical correlates / O. Levy // Nat. Rev. Immunol. – 2007 May. – Vol. 7, N 5. – P. 379–390.

Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immunе Ontogeny / T. R. Kollmann [et al.] // Immunity. – 2017 Mar. – Vol. 46, N 3. – P. 350–363.

Neutrophil left shift and white blood cell count as markers of bacterial infection / T. Honda [et al.] // Clin. Chim. Acta. –2016 Jun. – Vol. 457. – P. 46–53.

Вельков, В.В. Пресепсин - новый высокоэффективный биомаркер сепсиса / В.В. Вельков // Клинико-лабораторный консилиум. - 2012. - № 2

Новиков, Д. К. Клиническая иммунопатология : руководство / Д. К. Новиков, П. Д. Новиков. – Москва : Мед. лит.,2009. – 448 с.

Информативность уровней пресепсина для стратификации риска у пациентов после операций на сердце и сосудах / М.Г. Плющ, Е.А. Рогальская, Н.Н. Самсонова [и др.] // Лаборатория. - 2014. - № 2. - С. 49.

International Journal of Integrative and Modern Medicine

Significance of Presepsin in the Early Diagnosis of Sepsis in Children

Authors

Downloads

Similar Articles

submenu

counter